All In Biotech

Drug Trial Radar · NCT05979493

QL Block in Laparoscopic Myomectomy

Quadratus Lumborum Block to Improve Postoperative Pain Management After Laparoscopic Myomectomies: a Double-blinded and Prospective Randomized Clinical Trial.

Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Aug 24, 2024

Primary completion

Jul 1, 2028

Study completion Jul 3, 2028

Sponsor

Lead sponsor
Joseph Findley MDAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 7, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Supportive care
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.

Conditions

  • Postoperative Pain
  • Fibroid Uterus

Interventions

  • BupivacainDrug

    30cc IM injection in each quadratus lumborum muscle (60cc total).

  • SalineDrug

    30cc IM injection in each quadratus lumborum muscle (60cc total).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time in minutes from first analgesic request as measured by medical chart reviewTime frame: Up to 24 hours
  2. Total number of doses of rescue analgesics given as measured by medical chart reviewTime frame: Up to 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Hospitals Ahuja Medical Center

    Beachwood, Ohio · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.